DZ BANK upgraded Gerresheimer (ETR:GXI) to Buy in a report released today.
- Updated: September 18, 2016
Having a price of 74.47EUR, Gerresheimer (ETR:GXI) traded 0.00% even on the day. With the last stock close up 0.00% from the 200-day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. The company has recorded a 50-day average of 0.00EUR and two hundred day moving average of 0.00EUR. Trade volume was held steady, with 0 shares of GXI changing hands on par with the typical 0 shares.
DZ BANK has upgraded Gerresheimer(ETR:GXI) to Buy in a report released Monday September 19 2016.
With a market cap of 0.0 EUR, Gerresheimer has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR with a PE ratio of 0.
Brief Synopsis About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, and South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.